fda import alert semaglutide tirzepatide green list 'green list' flagging illegal GLP-1RA compounders is long overdue FDA Demurs on GLP-1 Compounding

FOXO4-DRI uses a unique mechanism targeting the FOXO4-p53 interaction specifically within senescent cells

This bridge program will now allow Medicare beneficiaries access to GLP-1 medications for weight loss through a monthly subscription model, which raises important questions about who pays, how much it will cost, and whether the program can be sustained long term, Kevin Thompson, the CEO of 9i Capital Group and the host of the 9innings podcast, told Newsweek

In clinical trials, semaglutide did not show a strong link to heart rhythm problems

GHS-R1a is encoded by the GHSR gene

Referral to an endocrinologist or specialist obesity clinic is particularly important if there is a suspected hormonal deficiency or if standard lifestyle measures have not achieved adequate weight management

Prevalence of GLP-1 medication exposure prior to, during, and after pregnancy using state-wide data from 2017 to 2023